Showing results (81-90 of 406) with videos related to
Sort By:
Pageof 41
Psychopharmacology|June 1, 1997
Central 5-HT2A and D2 dopamine receptor occupancy after sublingual administration of ORG 5222 in healthy menB Andrée, C Halldin, M Vrijmoed-de Vries, et al.Journal of Neurochemistry|December 1, 1990
Comparison of the in vitro receptor binding properties of N-[3H]methylspiperone and [3H]raclopride to rat and human brain membranesH Hall, I Wedel, C Halldin, et al.International Clinical Psychopharmacology|August 5, 1998
Implications of brain imaging for the management of schizophreniaS Nyberg, U Nilsson, Y Okubo, et al.Brain Research|January 16, 1997
Autoradiographic localization of 5-HT1A receptors in the post-mortem human brain using [3H]WAY-100635 and [11C]way-100635H Hall, C Lundkvist, C Halldin, et al.Nuclear Medicine and Biology|April 1, 1996
[11C]metaraminol, a false neurotransmitter: preparation, metabolite studies and positron emission tomography examination in monkeyK Någren, C Halldin, C G Swahn, et al.Nuclear Medicine and Biology|August 30, 2000
Use of PET and the radioligand [carbonyl-(11)C]WAY-100635 in psychotropic drug developmentB Andrée, C Halldin, S O Thorberg, et al.Psychopharmacology|October 20, 1999
A PET study of D(1)-like dopamine receptor ligand binding during altered endogenous dopamine levels in the primate brainY H Chou, P Karlsson, C Halldin, et al.Nuclear Medicine and Biology|June 26, 1999
Different brain radioactivity curves in a PET study with [11C]beta-CIT labelled in two different positionsC Lundkvist, C Halldin, C G Swahn, et al.Nuclear Medicine and Biology|November 14, 1997
[18F] beta-CIT-FP is superior to [11C] beta-CIT-FP for quantitation of the dopamine transporterC Lundkvist, C Halldin, N Ginovart, et al.The American Journal of Psychiatry|February 1, 1995
D2 dopamine receptor occupancy during low-dose treatment with haloperidol decanoateS Nyberg, L Farde, C Halldin, et al.Pageof 41